Výsledky vyhledávání - "X, Cos Claramunt"

[ESCRYTO study. Diabetes without cardiovascular disease and level of control]

Autor: M C, Gómez García, J M, Millaruelo Trillo, L, Avila Lachica, F X, Cos-Claramunt, J, Franch-Nadal, X, Cortés Gil

Publikováno v: Semergen. 46(4)

Diabetes is a significant risk factor for the development of cardiovascular disease, which is the main cause of death. The purpose of this study was to determine the level of glycaemic control in patients with type 2 diabetes without cardiovascular d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c19da7b6f2bfa0e12efaef28670ef6e9
https://pubmed.ncbi.nlm.nih.gov/31874786

Zobrazit plný text záznamu

[Blood glucose control and cardiovascular risk factors in type 2 diabetic patients with cardiovascular disease in Spain, and its treatment pattern, according to gender: CODICE study]

Autor: M C, Gómez García, J, Franch-Nadal, J M, Millaruelo Trillo, F X, Cos-Claramunt, L, Avila Lachica, P, Buil Cosiales

Publikováno v: Semergen. 46(2)

With the implementation of the Strategy of Health Promotion and Prevention in Spain, the scenario reflected in previous studies of low control of cardiovascular risk factors (CVRF) in patients with type 2 diabetes (DM2) and cardiovascular disease (CV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2c8df3698f771ceb8657edad290d4290
https://pubmed.ncbi.nlm.nih.gov/31399388

Zobrazit plný text záznamu

Liraglutida en el tratamiento de la diabetes tipo 2

Autor: M. Puig Domingo, J. Navarro Pérez, F.J. Ampudia-Blasco, X. Cos Claramunt, J.J. Mediavilla Bravo, J. García Alegría, P. Mezquita Raya, C. Calvo Gómez, E. Jódar Gimeno

Publikováno v: Avances en Diabetología. 26:226-234

Liraglutide is the first once daily human glucagonlike peptide-1 (GLP-1) analogue, with a 97% homology. Liraglutide has recently been approved by the European Medicines Agency and by the Food and Drug Administration to be used in the medical manageme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::34b22c31dd20a1ab629519a41a4458cd
https://doi.org/10.1016/s1134-3230(10)64003-3

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Diabetes mellitus tipo 2: incidencia y diagnóstico en un centro de atención primaria

Autor: E. Pujol Ribera, J. Davins Miralles, X. Cos Claramunt, M. Mata Cases, C. Royo Pastor, I. Bobé Molina, R. Centelles Fernández, R. Ortiz López, D. Ferrer-Vidal Cortella

Publikováno v: Atención Primaria. 25:469-474

ObjetivosConocer la incidencia anual, los motivos y los metodos utilizados para el diagnostico de diabetes mellitus tipo 2 (DM2) en el periodo 1991–1995 a partir de la validacion de un registro informatizado.DisenoEstudio longitudinal retrospectivo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee8dd150be51216c6486483c28d6c729
https://doi.org/10.1016/s0212-6567(00)78546-5

Zobrazit plný text záznamu

[Do the new criteria of the American Diabetes Association lead to earlier diagnosis of type-2 diabetes mellitus?]

Autor: M, Mata Cases, X, Cos Claramunt, E, Pujol Ribera, I, Bobé Molina, R, Centelles Fernández, R, Ortiz López, A, Ramos Fuertes, C, Royo Pastor

Publikováno v: Aten Primaria

OBJECTIVE: To analyze the period of time between the first occasional fasting hyperglycaemia (OFH) and the diagnosis of type 2 diabetes mellitus (DM2), using the World Health Organization (WHO) criteria or the American Diabetes Association (ADA) crit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f4c42a4c8a00f9cb62c65e4773d91398
https://pubmed.ncbi.nlm.nih.gov/11412573

Zobrazit plný text záznamu

[Type 2 diabetes mellitus: incidence and diagnosis at a primary care center]

Autor: M, Mata Cases, X, Cos Claramunt, I, Bobé Molina, E, Pujol Ribera, C, Royo Pastor, R, Centelles Fernández, J, Davins Miralles, D, Ferrer-Vidal Cortella, R, Ortiz López

Publikováno v: Aten Primaria

OBJECTIVE: To find the annual incidence and reasons for type-2 Diabetes Mellitus (DM2), and the methods used to diagnose it, on the basis of the validation of a computerised record for 1991–1995. DESIGN: Retrospective, longitudinal study. SETTING:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e721ba57839e552eeeb8c8016290784b
https://pubmed.ncbi.nlm.nih.gov/10851751

Zobrazit plný text záznamu

[Alternatives to population screening for breast cancer. Is the chance detection useful?]

Autor: R, Ciurana Misol, S, Calvet Junoy, C, Espel Masferrer, J M, Mendive Arbeloa, X, Cos Claramunt, C, Pareja Rossell, M, Nualart Feliu, I, Ibars Gibert, C, Muxí Moner, W, Mayo Aparicio, N, Moreno Muñoz

Publikováno v: Atencion primaria. 23(2)

1. To evaluate the characteristics of the demand, coverage and acceptability of random detection of breast cancer at a health centre (HC) between January 1995 and December 1996. 2. To describe the cases of breast cancer diagnosed since the setting up

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::49edad6f0a0b4cc3e70925eba15c8915
https://pubmed.ncbi.nlm.nih.gov/10081169

Zobrazit plný text záznamu

Autor: J. Morró i Pla, D. Martínez Laguna, X. Cos Claramunt, S. Martín-Urda Rodrigo, M. Mata Cases, T. Carrera Font

Publikováno v: Primary Care Diabetes. 7:89

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::47f5277a8e74398e576ec24726c7e7cb
https://doi.org/10.1016/j.pcd.2012.10.082

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání